drug value

Market Access

The journey to global market access for innovative therapies is fraught with challenges that vary significantly across the world.

Views & Analysis

Addressing the data and evidence gap in the early stages of asset development.

News

The FDA has raised the pressure on Amgen to withdraw vasculitis drug Tavneos from the market with a report linking serious side effects to the drug.

Sales & Marketing

As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.